Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD) and AMCI Acquisition Corp. II (Nasdaq: AMCI) announced this afternoon that they have adjourned their special meetings with shareholders.
Intelligent Medicine originally scheduled its meeting to be held today, but is now postponing its vote until Wednesday, February 8. Stockholders may elect to redeem their shares by no later than February 6.
The SPAC announced the pricing of its upsized $150 million IPO in November 2021. Although the SPAC has not yet found a target business to combine with, it intends to focus its efforts on life science companies that are using artificial intelligence, machine learning and big data to power drug discovery.
As for AMCI II, its special meeting, which was also scheduled for today, has been postponed until Monday, February 6. This marks the second adjournment for its meeting as it hopes to complete its transaction with sustainable materials-maker LanzaTech.
AMCI inked its $1.8 billion deal with LanzaTech in March 2022. The Chicago-based company is developing carbon-capture plants designed to provide a number of carbon negative outputs ranging from jet fuel to consumer packaging materials.
Terms Tracker for the Week Ending January 31, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This past week saw three new SPAC IPOs price, bringing the January and year-to-date IPO count to eight and underlining an active start to 2025....
The shortest month of the year nonetheless features new liquidity events for nine SPAC sponsors and 10 de-SPACs that at least a trio of which can be excited about. The de-SPACs being released from lock-ups this month with most to gain will also in most cases be the ones that will have to wait until...
Fifth Era Acquisition Corp I (NASDAQ:FERAU) has filed for a $200 million SPAC to potentially make another run at a blockchain or crypto transaction after the team’s first attempt fell short of sealing a deal. The new SPAC is offering investors a right to a 1/10 share in each unit, but it is not overfunded...
At the SPAC of Dawn It’s a handy trick to be able to tell the market you’re undervalued and have it respond by doubling your market cap on the day. That is roughly what went down yesterday with retail technology firm Alpha Modus (NASDAQ:AMOD) yesterday. Its CEO William Alessi took to a press release to...
At the SPAC of Dawn Another SPAC is joining the pack today with Stellar V Capital Corp. (NASDAQ:SVCCU) set to make its debut in today’s session, but there has also been news that could be encouraging for SPACs on the other end of their timeline. When faced with the choice of rushing whatever deal could...